Literature DB >> 9830355

Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.

V K Dhawan1, R Nachum, N Bhat, L Tolbert, M Agrawal.   

Abstract

We studied fecal colonization with vancomycin-resistant enterococci (VRE) in 89 HIV-infected nonhospitalized patients ages 24 to 62 years, including 70 (79%) men (including 41 homosexual and 5 bisexual men) and 19 (21%) women. Of the 89 patients, 61 (69%) were black, 25 (28%) Hispanic, and 3 (3%) white; 53 (60%) had history of ongoing or recent antibacterial therapy with trimethoprim/sulfamethoxazole (29), clarithromycin (18), amoxicillin (7), ofloxacin (3), and metronidazole, doxycycline, dicloxacillin, and cephalexin (1 each). VRE were not isolated from any of the patients studied.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830355      PMCID: PMC1305316     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  30 in total

1.  Vancomycin-resistant enterococci in turkeys and farmers.

Authors:  A E van den Bogaard; L B Jensen; E E Stobberingh
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

2.  Survey of enterococcal susceptibility patterns in Belgium.

Authors:  P Vandamme; E Vercauteren; C Lammens; N Pensart; M Ieven; B Pot; R Leclercq; H Goossens
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 3.  Resistance to glycopeptides in enterococci.

Authors:  R Leclercq; P Courvalin
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

4.  Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

Authors:  P K Linden; A W Pasculle; R Manez; D J Kramer; J J Fung; A D Pinna; S Kusne
Journal:  Clin Infect Dis       Date:  1996-04       Impact factor: 9.079

5.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

Review 6.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

7.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

8.  Enterococcal superinfection in patients treated with ciprofloxacin.

Authors:  M J Zervos; A E Bacon; J E Patterson; D R Schaberg; C A Kauffman
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

9.  Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community.

Authors:  I Klare; H Heier; H Claus; G Böhme; S Marin; G Seltmann; R Hakenbeck; V Antanassova; W Witte
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

Review 10.  The epidemiology of enterococci.

Authors:  C Chenoweth; D Schaberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

View more
  1 in total

1.  Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study.

Authors:  Wondwossen Abebe; Mengistu Endris; Moges Tiruneh; Feleke Moges
Journal:  BMC Public Health       Date:  2014-02-20       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.